Dextromethorphan metabolic phenotyping in a Chinese population

Acta Pharmacologica Sinica

Volumn 18, Issue 5, 1997, Pages 441-444

  Cai, Wei Min ^a   Chen, Bing ^a   Liu, Yu Xiu ^a   Chu, Xiao ^a,b  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Chinese; Cytochrome P 450 CYP2D6; Debrisoquin; Dextromethorphan; Hydroxylases; Pharmacogenetics; Phenotype; Polymorphism (genetics)

Indexed keywords

CYTOCHROME P450; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG METABOLITE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG METABOLISM; FEMALE; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOGENETICS; PHENOTYPE; URINALYSIS;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTOCHROME P-450 CYP2D6; DEXTROMETHORPHAN; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0030747181     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. BrØsen K, Gram LF. Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 1989; 36: 537-47.
2. Eichelbaum M, Gross AS. The genetic polymorphism of debrisoquine/sparteine metabolism-clinical aspects. Pharmacol Ther 1990; 46: 377-94.
3. Bertilsson L, Lou YQ, Du YL, Liu Y, Kuang TY, Liao XM, et al. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin. Clin Pharmacol Ther 1992; 51: 388-97.
4. Du YL, Lou YQ. Polymorphism of debrisoquine 4-hydroxylation and family studies of poor metabolizers in Chinese population. Acta Pharmacol Sin 1990; 11; 7-10.
5. Schmid B, Bircher J, Preisig R, Kupfer A. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylalion. Clin Pharmacol Ther 1985; 38: 618-24.
6. Guttendorf RJ, Britto M, Blouin RA, Foster TS, John W, Pittman KA, et al. Rapid screening for polymorphism in dextromethorphan and mephenytoin metabolism. Br J din Pharmacol 1990; 29: 373 - 80.
7. Hou ZY, Chen CP, Yang WC, Lai MD, Buchert ET, Chung HM, et al. Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis. Clin Pharmacol Ther 1996; 59: 411 - 7.
8. Gu XQ, editor. Encyclopaedia of Chinese medical science. Volume 1: Preventive medicine. Shanghai: Shanghai Science & Technology Publishing House, 1991: 344-6.
9. Lam YWF, Rodriguez SY. High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection. Ther Drug Monit 1993; 15: 300-4.
10. HoraiY, Nakano M, Ishizaki T, Ishikawa K, Zhou HH, Zhou BI, el al. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin Phannacol Ther 1989; 46: 198-207.
11. Hou ZY, Pickle LW, Meyer PS, Woosley RL. Salivary analysis for determination of dextromethorphan metabolic phenotype. Clin Pharmacol Ther 1991; 49: 410 - 9.